To further clarify the role of sequence polymorphism in patatin-like phospholipid domain containing protein 3 in the development of nonalcoholic fatty liver disease.
A sequence polymorphism in patatin-like phospholipid domain containing protein 3 is significantly associated with nonalcoholic fatty liver disease, but its mechanism underlying this association remains obscure. We introduce the human samples of liver to clarify the relationship between the expression of plin5 and the development of sequence polymorphism in patatin-like phospholipid domain containing protein 3 variant-associated nonalcoholic fatty liver disease, analyze the lipid metabolism and lipotoxicity of hepatocytes to elucidate the mechanisms of plin5 in the development of sequence polymorphism in patatin-like phospholipid domain containing protein 3 variant-associated nonalcoholic fatty liver disease. Our study will contribute to the mechanism of nonalcoholic fatty liver disease, and its prevention and therapy.
Study Type
OBSERVATIONAL
Enrollment
240
The Department of Ultrasonic Medicine, The Xijing Hospital of Fourth Military Medical University
Xi'an, Shaanxi, China
RECRUITINGThe severity of non-alcoholic fatty liver disease
Evaluating by ultrasound the severity of non-alcoholic fatty liver disease
Time frame: 3 months
The expression of plin5
Evaluating by biochemical methods the expression of plin5 in patients liver tissue
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.